Free Trial

Virpax Pharmaceuticals (VRPX) Insider Trading & Ownership

Virpax Pharmaceuticals logo
$0.73
+0.01 (+1.38%)
(As of 10/31/2024 ET)

Virpax Pharmaceuticals (NASDAQ:VRPX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.20%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$228,906.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get VRPX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Virpax Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRPX Insider Buying and Selling by Quarter

Virpax Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2022Jerrold SendrowDirectorBuy450$12.90$5,805.00  
5/18/2022Anthony P MackCEOBuy7,575$13.40$101,505.00  
5/18/2022Eric FloydDirectorBuy447$13.60$6,079.20  
11/22/2021Jerrold SendrowDirectorBuy390$39.20$15,288.00  
11/18/2021Anthony P MackCEOBuy2,512$39.90$100,228.80  
(Data available from 1/1/2013 forward)

VRPX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Virpax Pharmaceuticals includes Anthony P Mack, Eric Floyd, and Jerrold Sendrow. Learn more on insiders at VRPX.

4.20% of Virpax Pharmaceuticals stock is owned by insiders. Learn more on VRPX's insider holdings.



This page (NASDAQ:VRPX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners